82 results on '"Puente, J"'
Search Results
2. A constitutive model for rate-dependency analysis of open hole woven composites under compression loading
3. Experimental study of off-axis compression behaviour in dynamic loading: The open hole effect
4. High velocity impact response of carbon/epoxy composite laminates at cryogenic temperatures
5. HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies
6. Numerical study of composite fragment impacts onto rigid target
7. Experimental analysis of an attenuation method for Hydrodynamic Ram effects
8. Numerical methodology to analyze the ice impact threat: Application to composite structures
9. Experimental and numerical analysis of step drill bit performance when drilling woven CFRPs
10. The influence of laminate stacking sequence on ballistic limit using a combined Experimental/FEM/Artificial Neural Networks (ANN) methodology
11. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
12. Numerical Simulations of High Velocity Impacts of Composite Fragments
13. Numerical analysis of the influence of tool wear and special cutting geometry when drilling woven CFRPs
14. Experimental study of the impactor mass effect on the low velocity impact of carbon/epoxy woven laminates
15. Experimental analysis of normal and oblique high velocity impacts on carbon/epoxy tape laminates
16. Numerical prediction of delamination in CFRP drilling
17. Numerical analysis of high velocity impacts on unidirectional laminates
18. On the influence of filling level in CFRP aircraft fuel tank subjected to high velocity impacts
19. Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
20. Numerical analysis of CFRP fluid-filled tubes subjected to high-velocity impact
21. 1983P Feasibility and efficacy of split-dose cisplatin with atezolizumab for cisplatin-ineligible urothelial carcinoma (SOGUG-AUREA): Final results
22. Analysis of high velocity impacts of steel cylinders on thin carbon/epoxy woven laminates
23. Numerical modeling of ice behavior under high velocity impacts
24. Experimental study of CFRP fluid-filled tubes subjected to high-velocity impact
25. Analytical modelling of high velocity impacts of cylindrical projectiles on carbon/epoxy laminates
26. Impact behaviour of preloaded glass/polyester woven plates
27. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
28. Prediction of the behaviour of CFRPs against high-velocity impact of solids employing an artificial neural network methodology
29. Influence of conical projectile diameter on perpendicular impact of thin steel plate
30. 2409TiP A global, multicentre, open-label, randomised phase II trial of tobemstomig (tobe) with or without tiragolumab (tira) vs atezolizumab (atezo) in patients (pts) with untreated metastatic urothelial cancer (mUC) ineligible for platinum-based chemotherapy (chemo)
31. 2408TiP DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints
32. 1783P PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase
33. 2032MO Correlation of safety and efficacy in atezolizumab therapy across indications
34. An analytical model for high velocity impacts on thin CFRPs woven laminated plates
35. 147P Activity of single-agent PD-1/PD-L1 inhibitors in 1st-line (1L) “platinum-ineligible” patients (pts) with metastatic urothelial cancer (mUC) in real-life clinical practice
36. 1741P Atezolizumab (ATZ) with split-doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA): A multicentre, single-arm phase II trial
37. 1474P Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study)
38. Numerical modeling of the impact behavior of new particulate-loaded composite materials
39. Perte de masse de la viande congelée. Expérimentation et prévision à l'aide de la tylose
40. The effect of low temperatures on the intermediate and high velocity impact response of CFRPs
41. 1572P The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study
42. 606P Role of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results
43. 590P PRORADIUM: Prospective analysis of the impact of germline mutations in homologous recombination (HR) genes on the response to radium-223 for metastatic castration resistant prostate cancer (mCRPC)
44. One-stage model of foods freezing
45. LBA27 Phase II multicenter, randomized study to evaluate efficacy and safety of avelumab with gemcitabine/carboplatin (CG) vs CG alone in patients with unresectable or metastatic urothelial carcinoma (mUC) who are ineligible to receive cisplatin-based therapy
46. 692TiP BRCA2men: An international, multicentre, observational and ambispective study to validate the predictive value of germline BRCA2 mutations for selecting the first-line of treatment in metastatic castration-resistant prostate cancer (mCRPC)
47. 695TiP ORACULUM: A retrospective observational epidemiological study using artificial intelligence and natural language processing in electronic health records to characterize the prostate cancer pathway, management and outcomes in Europe, Middle East and Africa (EMEA region)
48. 628P Treatment in CARD eligible metastatic castration resistant prostate cancer (mCRPC) patients according to the status of germline HRR mutations: Cabazitaxel (CBZ) vs enzalutamide/abiraterone
49. 698O Patient-reported outcomes (PROs) from IMvigor130: A global, randomised, partially blinded phase III study of atezolizumab (atezo) + platinum-based chemotherapy (PBC) vs placebo (PBO) + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
50. 1819P - Clinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.